Zoledronic acid reduced fracture risk by 27% in men with metastatic prostate cancer receiving ADT in the STAMPEDE trial. Patients with non-metastatic disease showed no significant fracture benefit ...
May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...
Results suggest bone-protecting agents should be used in patients with metastatic castration-resistant prostate cancer and bone metastasis, especially in the era of androgen receptor pathway ...
SAN FRANCISCO—Men who undergo three-dimensional external beam radiotherapy (3D-EBRT) for prostate cancer may be at elevated risk for hip fractures, according to researchers. Using 1992-2005 data from ...
Efficacy of 177Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC: VISION secondary analysis. Safety profile of lutetium-177 in patients with impaired renal function: A retrospective ...
Prostate cancer may spread to your bones, causing pain and fractures. Jaundice can indicate that prostate cancer has spread to the liver. A chronic cough or shortness of breath may signal prostate ...
The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...
If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results